| Literature DB >> 18045471 |
Pia Fredriksson1, Niina Jaakkola, Jouni Jk Jaakkola.
Abstract
BACKGROUND: The question of the protective effect of breastfeeding on development of asthma has raised substantial interest, but the scientific evidence of the optimal duration of breastfeeding is controversial.Entities:
Mesh:
Year: 2007 PMID: 18045471 PMCID: PMC2228279 DOI: 10.1186/1471-2431-7-39
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Comparison of the 6-year cohort and the baseline study population, Espoo, Finland 1991–1997.
| Number | 2568 | 100 | 584 | 22.7 | 1984 | 77.3 |
| Age (years) | ||||||
| 1 | 424 | 16.5 | 100 | 17.1 | 324 | 16.3 |
| 2 | 405 | 15.8 | 104 | 17.8 | 301 | 15.2 |
| 3 | 310 | 16.0 | 92 | 15.8 | 318 | 16.0 |
| 4 | 400 | 15.6 | 67 | 11.5 | 333 | 16.8 |
| 5 | 415 | 16.2 | 101 | 17.3 | 314 | 15.8 |
| 6 | 391 | 15.2 | 81 | 13.9 | 310 | 15.6 |
| 7- | 123 | 4.8 | 39 | 6.7 | 84 | 4.2 |
| Gender | ||||||
| Boy | 1310 | 51.0 | 309 | 52.9 | 1001 | 50.5 |
| Girl | 1258 | 49.0 | 275 | 47.1 | 983 | 49.5 |
| Any allergic disease | ||||||
| Yes | 337 | 13.1 | 81 | 13.9 | 256 | 12.9 |
| No | 2231 | 86.9 | 503 | 86.1 | 1728 | 87.1 |
| Single parent/guardian | ||||||
| Yes | 183 | 7.1 | 53 | 9.1 | 130 | 6.6 |
| No | 2385 | 92.9 | 531 | 90.9 | 1854 | 93.4 |
| Highest level of parental education | ||||||
| Non-professional | 498 | 19.5 | 129 | 22.3 | 369 | 18.7 |
| Trade school | 663 | 25.9 | 140 | 24.2 | 523 | 26.5 |
| College or university | 1395 | 54.6 | 310 | 53.5 | 1085 | 54.9 |
| Missing information | 12 | |||||
| Exposure to ETS | ||||||
| Yes | 267 | 10.4 | 76 | 13.1 | 191 | 9.7 |
| No | 2291 | 89.6 | 504 | 86.9 | 1787 | 90.3 |
| Missing Information | 10 | |||||
| Gas stove | ||||||
| Yes | 86 | 3.4 | 24 | 4.1 | 62 | 3.1 |
| No | 2469 | 96.6 | 556 | 95.9 | 1913 | 96.9 |
| Missing Information | 13 | |||||
| Hairy/Feathery Pets | ||||||
| Yes | 480 | 18.7 | 113 | 19.3 | 367 | 18.5 |
| No | 2088 | 81.3 | 471 | 80.7 | 1617 | 81.5 |
| Type of day care | ||||||
| 100% Home | 940 | 36.6 | 210 | 36.0 | 730 | 36.8 |
| 100% Family | 513 | 20.0 | 119 | 20.4 | 394 | 19.9 |
| 100% Centre | 252 | 9.8 | 56 | 9.6 | 196 | 9.9 |
| Combinations | 863 | 33.6 | 199 | 34.1 | 664 | 33.5 |
Figure 1Prevalence of current asthma, persistent wheezing, cough and phlegm at the end of the follow-up period according to duration of breastfeeding.
Prevalence of current asthma, persistent wheezing, cough, and phlegm at the end of the follow-up period (N = 1933).
| 0–3 months (N = 346) | 27 | 7.8 | 17 | 4.9 | 27 | 7.8 | 25 | 7.3 |
| 4–6 months (N = 385) | 20 | 14 | 3.6 | 22 | 5.7 | 20 | 5.2 | |
| 7–9 months (N = 528) | 32 | 6.0 | 14 | 22 | 15 | |||
| 10–12 months (N = 434) | 37 | 8.5 | 13 | 3.0 | 21 | 4.8 | 21 | 4.8 |
| > 12 months (N = 240) | 21 | 8.8 | 16 | 6.7 | 17 | 7.1 | 19 | 7.9 |
* Number of individuals with the health outcome
The relation between the duration of breastfeeding and the risks of current asthma, persistent wheezing, cough, and phlegm at the end of the follow-up period (N = 1933).
| 0–3 months | 1.44 | 0.78, 2.66 | 1.64 | 0.77, 3.52 | 1.72 | 0.94, 3.15 | 2.38 | 1.20, 4.70 |
| 4–6 months | 1.00 (reference) | 1.38 | 0.64, 2.97 | 1.35 | 0.73, 2.50 | 1.90 | 0.95, 3.79 | |
| 7–9 months | 1.16 | 0.65, 2.08 | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) | |||
| 9–12 months | 1.72 | 0.97, 2.08 | 1.15 | 0.53, 2.50 | 1.21 | 0.65, 2.25 | 1.87 | 0.95, 3.71 |
| > 12 months | 1.60 | 0.83, 2.08 | 2.26 | 1.07, 4.79 | 1.63 | 0.84, 3.16 | 2.88 | 1.42, 5.84 |
| From optimal to shorter per month † | 1.10 | 0.92, 1.32 | 1.12 | 0.99, 1.19 | 1.08 | 0.98, 1.19 | 1.11 | 1.00, 1.24 |
| From optimal to longer per month ‡ | 1.03 | 1.00, 1.05 | 1.05 | 1.03, 1.08 | 1.04 | 1.02, 1.06 | 1.04 | 1.01, 1.06 |
* Adjusted in logistic regression analysis for age, gender, parent's highest education, single parent or guardian, exposure to environmental tobacco smoke (ETS), smoking during pregnancy, parental atopy, and parental asthma, presence of hairy or feathery pets at home or type of day care during the past year
† Optimal was 7 months for asthma and 9 months for chronic respiratory symptoms
‡ Optimal 7 months